Investigators Observe Differences in Toxicity for Sarcoma Due to DosingByGary K. Schwartz, MDJuly 14th 2020Gary K. Schwartz, MD, discusses adverse events seen in patients with metastatic sarcoma participating in the Alliance A091401 trial.